A compound that showed early promise in the treatment of Parkinson's disease in fruit flies has also shown neuroprotective ...

Marc Cohn, a Cleveland native and a Grammy Award-winning singer best known for his hit "Walking in Memphis," revealed he was ...

Veterans diagnosed with post-traumatic stress disorder may experience thrashing sleep, which can lead to more extensive ...

A report released today by The National Alliance for Caregiving (NAC), with support from The Michael J. Fox Foundation for Parkinson's Research (MJFF) and Arcadia University, uncovers the immense, ...

Jupiter, Florida, Feb. 03, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company developing JOTROL™, a patented resveratrol-based platform, ...

A 3D model has been developed that accurately replicates the complex structures of cerebral blood vessels, enabling ...

Passed away peacefully after a long battle with Parkinson's Disease surrounded by her loving family. Loving wife of John.

Serina Therapeutics (SER) announced the closing of the second $5M tranche of its previously announced $10M equity financing with strategic ...

Michael J. Fox might have a wholesome reputation these days, but he and a bunch of his celebrity friends once got busted by the cops.

Shares of Serina Therapeutics advanced in the after-hours market after the company said it closed on a $5 million tranche of equity financing. The stock rose 6.5% to $5.23 post-market, adding to the 4 ...

The next big advance in treating diseases like rheumatoid arthritis could be tiny pulses of electricity delivered to the ...

JUPITER, FL - Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a clinical-stage pharmaceutical company currently valued at $34.1 million, has announced a partnership with Catalent (NYSE:CTLT) Pharma ...